Back to News

29 Jul 2020

Hetero Launches Generic COVID-19 Treatment Drug Favipiravir in India under brand name FAVIVIR

Gastro Division

After Covifor Injection, Hetero developed the second drug 'Favipiravir' for treatment of mild to moderate Coronavirus symptoms following the approvals from the Drug Controller General of India (DCGI) to manufacture and market the generic drug under the brand name Favivir. It is an oral antiviral medicine that has exhibited positive clinical results.